Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Tuberculosis
Researchers tweak TB treatment assay to support global use
By
Nick Paul Taylor
Researchers have developed a tuberculosis (TB) treatment assay that could be a faster, simpler method for monitoring patients.
April 10, 2024
WHO launches new guidance on TB diagnostics
By
LabPulse.com staff writers
The World Health Organization has published updated guidance for the diagnosis of tuberculosis (TB), including new recommendations on the use of next-generation sequencing for the diagnosis of drug-resistant TB.
March 21, 2024
Danaher cuts cost of rapid TB test after years of pressure from activists
By
Nick Paul Taylor
Danaher has cut the cost of one of its tuberculosis (TB) tests in less developed countries after years of public pressure to lower the price.
September 21, 2023
PBD receives U.S. patent for phage-based tuberculosis diagnostic kit
By
Nick Paul Taylor
PBD is using its expertise in phages to develop Actiphage, a test designed to detect the active mycobacteria that cause tuberculosis in blood samples.
August 1, 2023
Lab-on-a-chip tech enables fast, cheap tuberculosis detection in study
By
Nick Paul Taylor
The St George’s and QuantuMDx collaborators identified dielectrophoresis as a way to improve testing for TB. Using the technique, the researchers isolated the bacteria that cause TB from the rest of the content of sputum samples.
July 3, 2023
Dielectrophoresis may enable the diagnosis of 'missing millions' of tuberculosis cases
By
Elissa Wolfson
The disease-causing bacterium Mycobacterium tuberculosis was selectively isolated using new chip-based technology on sputum samples from suspected tuberculosis patients.
June 22, 2023
Qiagen describes systematic review for IGRA TB test, blood collection tubes
By
Leo O'Connor
The study including 4,050 subjects highlights the value of the TB2 tube and the detection of CD8 T-cell responses for immunocompromised patients, a key risk group for tuberculosis disease, the firm said.
June 15, 2023
USPSTF recommends screening for latent tuberculosis
By
Elissa Wolfson
USPSTF found that available tests — in particular, the tuberculin skin test and interferon-γ release assays — were sufficiently accurate to identify persons with LTBI who might benefit from treatment to prevent progression to active tuberculosis.
May 2, 2023
Noze nabs $1M grant from Bill & Melinda Gates Foundation to develop breath testing platform
By
LabPulse.com staff writers
The aim is to develop a platform that enables rapid screening and diagnostic testing for infectious diseases such as malaria and tuberculosis that impact millions of people, particularly in developing countries, Noze said.
March 14, 2023
Roche, CDC expand partnership on HIV and TB support for healthcare systems in critical regions
By
Maryam Payne
The public-private partnership, named Lab Networks for Health, aims to improve HIV and TB detection, prevention, and treatment in countries that have been hit hardest by the two diseases.
February 28, 2023
Qiagen obtains CE Mark for tuberculosis blood test
By
LabPulse.com staff writers
Qiagen’s Ipsogen JAK2 RGQ PCR kit and NeuMoDx systems and reagents have already received CE Marks under the new IVDR requirements; the firm has pledged to transition all of its products to meet the new EU IVDR regulations.
February 15, 2023
Bill & Melinda Gates Foundation awards $14.2M in grants to LumiraDx to develop TB testing system
By
LabPulse.com staff writers
With support from the foundation, LumiraDx is developing a portable system to provide testing at a lower cost and incorporate a tongue swab that makes it easier for a higher percentage of patients to be tested.
December 14, 2022
Page 1 of 2
Next Page
